Ann Lee

Ann Lee

Hoofd Techniek/Wetenschap/O&O bij PRIME MEDICINE, INC.

Vermogen: 439 249 $ op 31-05-2026

64 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Ann L.
Lee
currently serves as Director at the American Institute of Chemical Engineers, Alliance for Regenerative Medicine, and JW Therapeutics (Shanghai) Co., Ltd. Dr. Lee is an Independent Director at Coya Therapeutics, Inc. since 2021.
Dr. Lee is a Member of the Washington State Academy of Sciences and the National Academy of Engineering.
Since 2021, Dr. Lee has been Chief Technical Officer at Prime Medicine, Inc. Former roles include Director at JW (Cayman) Therapeutics Co. Ltd., SVP, Head of Cell Therapy Development & Operations at Bristol Myers Squibb Co. from 2019 to 2021, EVP-Cell Therapy Development & Operations at Celgene Corp.
from 2018 to 2019, SVP & Global Head-Pharma Technical Development at Genentech, Inc. from 2009 to 2017, VP-Chemical Technology & Engineering at Merck Research Laboratories Massachusetts LLC, VP-Process Engineering & Technical Operations at Merck & Co., Inc. from 1989 to 2005, SVP & Head-Global Technical Development at Roche Corp.
from 2010 to 2017, and Executive Vice President-Technical Operations at Juno Therapeutics, Inc. from 2017 to 2018.
Education includes undergraduate degree from Cornell University and graduate and doctorate degrees from Yale University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
31-03-2026 100.000 ( 0,06% ) 355 000 $ 31-05-2026
01-05-2026 17.479 ( 0,07% ) 84 249 $ 31-05-2026

Actieve functies van Ann Lee

BedrijvenFunctieBegin
PRIME MEDICINE, INC. Hoofd Techniek/Wetenschap/O&O 01-10-2021
COYA THERAPEUTICS, INC. Directeur/Bestuurslid 01-06-2021
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Corporate Officer/Principal -
Directeur/Bestuurslid -
Corporate Officer/Principal -

Eerdere bekende functies van Ann Lee

BedrijvenFunctieEinde
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01-07-2021
CELGENE Corporate Officer/Principal 01-11-2019
░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Ann Lee in detail bekijken

Opleiding van Ann Lee

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

88

Eerstegraads connecties

17

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit17

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Roche Corp.

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

-40 %: de beste tools exclusief voor abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU